ChemicalBook >> CAS DataBase List >>3-Pyridazinecarboxylic acid, N1-[N-(2,5-anhydro-3,4-dideoxy-3-phenyl-L-threo-pentonoyl)-N-methyl-L-valyl-3-[(2S)-1-ethyl-3-(3-hydroxy-2,2-dimethylpropyl)-2-[2-[(1S)-1-methoxyethyl]-5-(4-methyl-1-piperazinyl)-3-pyridinyl]-1H-indol-5-yl]-5-hydroxy-L-phenylalanyl]hexahydro-, (3→23)-lactone, (3S)-
3-Pyridazinecarboxylic acid, N1-[N-(2,5-anhydro-3,4-dideoxy-3-phenyl-L-threo-pentonoyl)-N-methyl-L-valyl-3-[(2S)-1-ethyl-3-(3-hydroxy-2,2-dimethylpropyl)-2-[2-[(1S)-1-methoxyethyl]-5-(4-methyl-1-piperazinyl)-3-pyridinyl]-1H-indol-5-yl]-5-hydroxy-L-phenylalanyl]hexahydro-, (3→23)-lactone, (3S)-
- CAS No.
- 2642135-72-4
- Chemical Name:
- 3-Pyridazinecarboxylic acid, N1-[N-(2,5-anhydro-3,4-dideoxy-3-phenyl-L-threo-pentonoyl)-N-methyl-L-valyl-3-[(2S)-1-ethyl-3-(3-hydroxy-2,2-dimethylpropyl)-2-[2-[(1S)-1-methoxyethyl]-5-(4-methyl-1-piperazinyl)-3-pyridinyl]-1H-indol-5-yl]-5-hydroxy-L-phenylalanyl]hexahydro-, (3→23)-lactone, (3S)-
- Synonyms
- Pan-RAS-IN-7;3-Pyridazinecarboxylic acid, N1-[N-(2,5-anhydro-3,4-dideoxy-3-phenyl-L-threo-pentonoyl)-N-methyl-L-valyl-3-[(2S)-1-ethyl-3-(3-hydroxy-2,2-dimethylpropyl)-2-[2-[(1S)-1-methoxyethyl]-5-(4-methyl-1-piperazinyl)-3-pyridinyl]-1H-indol-5-yl]-5-hydroxy-L-phenylalanyl]hexahydro-, (3→23)-lactone, (3S)-
- CBNumber:
- CB09835258
- Molecular Formula:
- C59H76N8O8
- Molecular Weight:
- 1025.29
- MDL Number:
- MOL File:
- 2642135-72-4.mol
Last updated:2025-04-17 18:22:24
3-Pyridazinecarboxylic acid, N1-[N-(2,5-anhydro-3,4-dideoxy-3-phenyl-L-threo-pentonoyl)-N-methyl-L-valyl-3-[(2S)-1-ethyl-3-(3-hydroxy-2,2-dimethylpropyl)-2-[2-[(1S)-1-methoxyethyl]-5-(4-methyl-1-piperazinyl)-3-pyridinyl]-1H-indol-5-yl]-5-hydroxy-L-phenylalanyl]hexahydro-, (3→23)-lactone, (3S)- Properties
| Density | 1.29±0.1 g/cm3(Predicted) |
|---|---|
| pka | 9.71±0.60(Predicted) |
3-Pyridazinecarboxylic acid, N1-[N-(2,5-anhydro-3,4-dideoxy-3-phenyl-L-threo-pentonoyl)-N-methyl-L-valyl-3-[(2S)-1-ethyl-3-(3-hydroxy-2,2-dimethylpropyl)-2-[2-[(1S)-1-methoxyethyl]-5-(4-methyl-1-piperazinyl)-3-pyridinyl]-1H-indol-5-yl]-5-hydroxy-L-phenylalanyl]hexahydro-, (3→23)-lactone, (3S)- Chemical Properties, Uses, Production
3-Pyridazinecarboxylic acid, N1-[N-(2,5-anhydro-3,4-dideoxy-3-phenyl-L-threo-pentonoyl)-N-methyl-L-valyl-3-[(2S)-1-ethyl-3-(3-hydroxy-2,2-dimethylpropyl)-2-[2-[(1S)-1-methoxyethyl]-5-(4-methyl-1-piperazinyl)-3-pyridinyl]-1H-indol-5-yl]-5-hydroxy-L-phenylalanyl]hexahydro-, (3→23)-lactone, (3S)- Preparation Products And Raw materials
Raw materials
Preparation Products
3-Pyridazinecarboxylic acid, N1-[N-(2,5-anhydro-3,4-dideoxy-3-phenyl-L-threo-pentonoyl)-N-methyl-L-valyl-3-[(2S)-1-ethyl-3-(3-hydroxy-2,2-dimethylpropyl)-2-[2-[(1S)-1-methoxyethyl]-5-(4-methyl-1-piperazinyl)-3-pyridinyl]-1H-indol-5-yl]-5-hydroxy-L-phenylalanyl]hexahydro-, (3→23)-lactone, (3S)- Suppliers
Global Suppliers ( 3)
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Shanghai Tachizaki Biomedical Research Center | 18014399201 | sales@chemlab-tachizaki.com | China | 2934 | 58 |
| TargetMol Chemicals Inc. | 15002134094 | marketing@targetmol.cn | China | 29874 | 58 |
| Afflon Pharmaceutical (Sichuan) Co., Ltd. | 17336178085 | 1684779048@qq.com | China | 2263 | 58 |
| Supplier | Advantage |
|---|---|
| Shanghai Tachizaki Biomedical Research Center | 58 |
| TargetMol Chemicals Inc. | 58 |
| Afflon Pharmaceutical (Sichuan) Co., Ltd. | 58 |
2642135-72-4 (3-Pyridazinecarboxylic acid, N1-[N-(2,5-anhydro-3,4-dideoxy-3-phenyl-L-threo-pentonoyl)-N-methyl-L-valyl-3-[(2S)-1-ethyl-3-(3-hydroxy-2,2-dimethylpropyl)-2-[2-[(1S)-1-methoxyethyl]-5-(4-methyl-1-piperazinyl)-3-pyridinyl]-1H-indol-5-yl]-5-hydroxy-L-phenylalanyl]hexahydro-, (3→23)-lactone, (3S)-) Related Search:
2-Propen-1-one, 1-[(3S)-4-[(7R)-7-[6-amino-4-methyl-3-(trifluoromethyl)-2-pyridinyl]-6-chloro-8-fluoro-2-[[(2S)-1-methyl-2-pyrrolidinyl]methoxy]-4-quinazolinyl]-3-methyl-1-piperazinyl]-
2,7-Diazaspiro[4.4]nonane-2-acetamide, α-cyclopentyl-7-[[(2R,3R)-3-cyclopropyl-1-methyl-2-aziridinyl]carbonyl]-N-[(1R,10S,12S,18S)-1-[5-(4-cyclopropyl-1-piperazinyl)-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-2,7,8,10,11,12,13,16,17,18,19,21,22,23-tetradecahydro-22,22-dimethyl-13,19-dioxo-2-(2,2,2-trifluoroethyl)-15H-3,5-etheno-14,18-imino-6,10-methano-6H-pyrrolo[3,4-g][1,12,4,18]dioxadiazacyclodocosin-12-yl]-, (αS,5S)-
1,4-Oxazepin-5(2H)-one, 4-[3-[[2-[[2-ethyl-4-(4-methyl-1-piperazinyl)phenyl]amino]-5-(trifluoromethyl)-4-pyrimidinyl]amino]propyl]tetrahydro-
RMC-7977
EHT1864
1of2
Pan-RAS-IN-7
3-Pyridazinecarboxylic acid, N1-[N-(2,5-anhydro-3,4-dideoxy-3-phenyl-L-threo-pentonoyl)-N-methyl-L-valyl-3-[(2S)-1-ethyl-3-(3-hydroxy-2,2-dimethylpropyl)-2-[2-[(1S)-1-methoxyethyl]-5-(4-methyl-1-piperazinyl)-3-pyridinyl]-1H-indol-5-yl]-5-hydroxy-L-phenylalanyl]hexahydro-, (3→23)-lactone, (3S)-
2642135-72-4
C59H76N8O8




